Factors associated with COVID-19 vaccine hesitancy in Senegal: A mixed study.


Journal

Human vaccines & immunotherapeutics
ISSN: 2164-554X
Titre abrégé: Hum Vaccin Immunother
Pays: United States
ID NLM: 101572652

Informations de publication

Date de publication:
30 11 2022
Historique:
pubmed: 12 5 2022
medline: 7 7 2022
entrez: 11 5 2022
Statut: ppublish

Résumé

This study was an explanatory, sequential, mixed-methods design conducted in Senegal. We collected quantitative data from December 24, 2020, to January 16, 2021, and qualitative data from February 19 to March 30, 2021. We conducted a telephone survey among a marginal quota sample of 607 people over 18 years old. We performed descriptive, bivariate, and multivariate analyses with R software for the quantitative phase; and performed manual content analyses for the qualitative phase. We surveyed 607 people for the quantitative phase and interviewed 30 people for the qualitative phase. Individuals who hesitated or refused to be vaccinated represented 12.9% and 32.8%, respectively. Vaccine hesitancy was related to gender, living in large cities, having a poor attitude toward the vaccine, thinking that the vaccine would not help protect them from the virus, being influenced by people important to them, and lacking information from health professionals. Vaccine refusal was related to living in large cities, having a poor attitude toward the vaccine, thinking that the vaccine would not help protect them from the virus, thinking that the vaccine could endanger their health, trusting opinions of people who were important to them, and lacking information from health professionals. The results of the study show that the factors associated with COVID-19 vaccine hesitancy and refusal are diverse and complex. Addressing these factors will help to ensure better vaccination coverage. Governments and health authorities should intensify their efforts to promote vaccine confidence and reduce misinformation.

Identifiants

pubmed: 35543616
doi: 10.1080/21645515.2022.2060020
pmc: PMC9897646
doi:

Substances chimiques

COVID-19 Vaccines 0
Vaccines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2060020

Références

J Radiol Nurs. 2021 Jun;40(2):116-119
pubmed: 33727900
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
Hum Vaccin Immunother. 2020 May 3;16(5):1007-1017
pubmed: 32298198
Vaccines (Basel). 2021 Jan 12;9(1):
pubmed: 33445581
Global Health. 2022 Feb 4;18(1):10
pubmed: 35120537
Vaccines (Basel). 2021 Jun 17;9(6):
pubmed: 34204465
Public Health. 2021 May;194:245-251
pubmed: 33965796
Vaccine. 2020 Nov 17;38(49):7789-7798
pubmed: 33109389
Ann Transl Med. 2016 Mar;4(6):111
pubmed: 27127764
PLoS Negl Trop Dis. 2022 Jan 28;16(1):e0010103
pubmed: 35089917
Eur J Epidemiol. 2020 Aug;35(8):775-779
pubmed: 32785815
Hum Vaccin Immunother. 2021 Jun 3;17(6):1612-1621
pubmed: 33242386
Nat Rev Dis Primers. 2021 Jun 10;7(1):41
pubmed: 34112811
Int J Environ Res Public Health. 2021 Jan 19;18(2):
pubmed: 33477825
Hum Vaccin Immunother. 2021 Jul 3;17(7):2279-2288
pubmed: 33522405
Vaccines (Basel). 2021 Mar 22;9(3):
pubmed: 33810131
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Vaccine. 2021 Apr 8;39(15):2024-2034
pubmed: 33722411
Trans R Soc Trop Med Hyg. 2022 Dec 2;116(12):1214-1222
pubmed: 36222221
Influenza Other Respir Viruses. 2021 May;15(3):361-370
pubmed: 33605010
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):217-222
pubmed: 33571174
Clin Infect Dis. 2020 Jul 28;71(15):703-705
pubmed: 32282038
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Front Med (Lausanne). 2020 Jun 23;7:348
pubmed: 32671082
Vaccines (Basel). 2021 May 24;9(6):
pubmed: 34073757
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
J Community Health. 2021 Apr;46(2):270-277
pubmed: 33389421
Mayo Clin Proc. 2021 Mar;96(3):699-707
pubmed: 33673921
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
Hum Vaccin Immunother. 2021 Nov 2;17(11):3907-3912
pubmed: 34280070
Vaccines (Basel). 2020 Dec 18;8(4):
pubmed: 33352835
Br J Health Psychol. 2020 Nov;25(4):1039-1054
pubmed: 32889759
J Acquir Immune Defic Syndr. 2021 Feb 1;86(2):200-207
pubmed: 33196555
Vaccines (Basel). 2021 Jan 13;9(1):
pubmed: 33451104
BMC Infect Dis. 2021 Jan 28;21(1):120
pubmed: 33509104
Hum Vaccin Immunother. 2021 Nov 2;17(11):4057-4064
pubmed: 34613864
Lancet Reg Health West Pac. 2021 Sep;14:100241
pubmed: 34377999
Hum Vaccin Immunother. 2020 Nov 1;16(11):2586-2593
pubmed: 32693678
Pragmat Obs Res. 2020 Oct 29;11:103-109
pubmed: 33154695
Public Health. 2021 Aug;197:e18-e19
pubmed: 33714553
Health Policy Plan. 2018 Apr 1;33(3):445-455
pubmed: 29365123

Auteurs

Mouhamadou Faly Ba (MF)

Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.

Adama Faye (A)

Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.

Babacar Kane (B)

Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.

Amadou Ibra Diallo (AI)

Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.

Amandine Junot (A)

STAPS Department, Faculty of Human and Environmental Sciences, La Réunion University, Le-Tampon, Réunion.

Ibrahima Gaye (I)

Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.

Emmanuel Bonnet (E)

IRD, UMR 215 Prodig, Aubervilliers, France.

Valéry Ridde (V)

Institute of Health and Development (ISED), Cheikh Anta Diop University, Dakar, Senegal.
ERL INSERM SAGESUD, CEPED, IRD-University of Paris, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH